Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kiwa Bio-Tech Products Group Corp (KWBT)

Kiwa Bio-Tech Products Group Corp (KWBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiwa Bio-Tech Products Group Corp 3200 Guasti Road Suite #100 Ontario CA 91761 USA

www.kiwabiotech.com P: 909-456-8828

Description:

Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. It also develops a veterinary drug based on AF-01 anti-viral aerosol technology, an antiviral agent with potent inhibitory and/or viricidal effects on RNA viruses found in animals and fowls. In addition, Kiwa Bio-Tech Products Group, through its joint venture with Tianjin Challenge Feed Co., Ltd., develops, manufactures, and markets bio-feed products for livestock. It also has joint venture with Hebei Huaxing Pharmaceuticals Co., Ltd that develops, manufactures, and markets animal drugs and disinfectants, including AF-01 anti-viral aerosol technology-based products.

Key Statistics

Overview:

Market Capitalization, $K 3
Enterprise Value, $K -7
Shares Outstanding, K 16,890
Annual Sales, $ 40,090 K
Annual Net Income, $ -6,640 K
EBIT, $ 0 K
EBITDA, $ -1,140 K
60-Month Beta 2.88
% of Insider Shareholders 1.27%
% of Institutional Shareholders 0.00%
Float, K 144,886
% Float 98.73%
Short Volume Ratio 0.69

Growth:

1-Year Return 0.00%
3-Year Return -96.77%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 12/31/20
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-200 on 01/28/16

KWBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -16.56%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -0.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar